-
1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
-
ChemBase ID:
1379
-
Molecular Formular:
C21H27N3O7S
-
Molecular Mass:
465.51998
-
Monoisotopic Mass:
465.15697122
-
SMILES and InChIs
SMILES:
S1[C@H]2N([C@H](C1(C)C)C(=O)OC(OC(=O)OCC)C)C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1
Canonical SMILES:
CCOC(=O)OC(OC(=O)[C@@H]1N2C(=O)[C@H]([C@H]2SC1(C)C)NC(=O)[C@@H](c1ccccc1)N)C
InChI:
InChI=1S/C21H27N3O7S/c1-5-29-20(28)31-11(2)30-19(27)15-21(3,4)32-18-14(17(26)24(15)18)23-16(25)13(22)12-9-7-6-8-10-12/h6-11,13-15,18H,5,22H2,1-4H3,(H,23,25)/t11?,13-,14-,15+,18-/m1/s1
InChIKey:
PFOLLRNADZZWEX-FFGRCDKISA-N
-
Cite this record
CBID:1379 http://www.chembase.cn/molecule-1379.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
|
IUPAC Traditional name
|
bacampicilline
|
bacampicillin
|
|
|
Brand Name
|
|
Synonyms
|
Bacampicillin Hydrochloride
|
Bacampicillin
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEBI ID
|
|
ATC CODE
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
11.7201185
|
H Acceptors
|
6
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-0.4384752
|
LogD (pH = 7.4)
|
1.1510522
|
Log P
|
1.4712881
|
Molar Refractivity
|
113.7604 cm3
|
Polarizability
|
45.85553 Å3
|
Polar Surface Area
|
137.26 Å2
|
Rotatable Bonds
|
10
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.17
|
LOG S
|
-3.58
|
Solubility (Water)
|
1.23e-01 g/l
|
PROPERTIES
PROPERTIES
Pharmacology Properties
Bioassay(PubChem)
Admin Routes
|
Oral
|
Show
data source
|
|
Metabolism
|
Rapidly hydrolyzed to ampicillin
|
Show
data source
|
|
DETAILS
DETAILS
DrugBank
Wikipedia
DrugBank -
DB01602
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Bacampicillin is a prodrug of ampicillin and is microbiologically inactive. It is absorbed following oral administration. During absorption from the gastrointestinal tract, bacampicillin is hydrolyzed by esterases present in the intestinal wall. It is microbiologically active as ampicillin, and exerts a bactericidal action through the inhibition of the biosynthesis of cell wall mucopeptides. It is used to cure infection of upper and lower respiratory tract; skin and soft tissue; urinary tract and acute uncomplicated gonococcal urethritis etc. |
Indication |
For infections at the following sites: upper and lower respiratory tract; skin and soft tissue; urinary tract and acute uncomplicated gonococcal urethritis, when due to sensitive strains of the following organisms: Gram-positive: streptococci (including S. faecalis and S. pneumoniae) and nonpenicillinase-producing staphylococci; Gram-negative: H. influenzae, N. gonorrhoeae, E. coli, P. mirabilis, Salmonellae and Shigellae. |
Pharmacology |
Bacampicillin is a prodrug of ampicillin and is microbiologically inactive. |
Affected Organisms |
• |
Enteric bacteria and other eubacteria |
|
Absorption |
Absorbed following oral administration. |
External Links |
|
|
PATENTS
PATENTS
PubChem Patent
Google Patent